Overview
Precision Instruments

Precision System Science Co.,Ltd.

Precision System Science Co., Ltd. develops, manufactures, and sells automated laboratory instruments and clinical diagnostic devices focused on nucleic acid extraction and genetic analysis, along with related reagents and consumables (reaction vessels, PCR reagents, etc.). The company operates primarily through ODM partnerships with major global life science companies, supplemented by direct sales in Japan and through European subsidiaries. Its customer base spans universities, research institutions, clinical testing centers, pharmaceutical companies, and chemical manufacturers worldwide.

Market Cap
¥5.79B
US$37.0M
EV
¥5.42B
US$34.6M
Stock¥211▲+1.44%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
13.3
x
LTM EV/EBIT
27.0
x
LTM PER
14.7
x
LTM PBR
1.4
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-6.6%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
5.79BUS$37.0MMarket Cap1.03BUS$6.54M+ Debt1.37BUS$8.71M− Cash0.03BUS$0.22M− Inv. Sec.5.42BUS$34.6MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
7.43US$47.4M'22/65.28US$33.7M'23/63.98US$25.4M'24/64.69US$29.9M'25/65.22US$33.3M'26/6
EBITDA 5Y (¥B)
0.69US$4.38M'22/6-0.47-US$3.00M'23/6-0.55-US$3.49M'24/60.12US$0.75M'25/60.41US$2.61M'26/6
Net Income 5Y (¥B)
0.05US$0.29M'22/6-1.32-US$8.44M'23/6-1.12-US$7.15M'24/6-0.25-US$1.61M'25/60.39US$2.51M'26/6
Capital Structure
80%
20%
EquityD/E 0.25xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
2.80US$17.9M4.02US$25.6M'22/62.53US$16.1M3.87US$24.7M'23/61.97US$12.6M1.37US$8.72M'24/61.07US$6.83M0.56US$3.60M'25/61.40US$8.93M1.03US$6.54M'26/6
Shareholders
Top 10 hold 31.2%
1
Shuji TAJIMA
16.77%
2
Unitec Co., Ltd.
4.36%
3
SBI SECURITIES Co., Ltd.
2.96%
4
Daisuke SEIBAN
2.41%
5
Rakuten Securities, Inc.
1.39%
6
Wataru ARAI
1.30%
7
Hiroyuki KODAMA
0.51%
8
Kenta ITO
0.51%
9
NOMURA INTERNATIONAL PLC A/C JAPAN FLOW (Standing Proxy: Nomura Securities Co., Ltd.)
0.48%
10
Shigeru TAKAHASHI
0.48%
Management
9 officers
Yu SUGIYAMA
Representative Director, President
May 2015 Joined the Company Seconded to Universal Bio Research Co., Ltd., attached to Administration Division Oct 2018 Head of Business Strategy Office, Sales Division Jul 2022 General Manager, Sales Management Division Apr 2023 Executive Officer, General Manager, Sales Management Division Sep 2024 Representative Director, President (current)
1986-03-12
Ryoji KARINAGA
Director
Apr 2005 Joined the Company, Development Department No. 1, Research & Development Division Jul 2011 Manager, Development Department No. 1, Research & Development Division Jun 2015 Joined Eiken Chemical Co., Ltd. Jul 2020 Joined the Company, Assistant Manager, Academic Affairs Department Nov 2022 Joined Fujimori Kogyo Co., Ltd. Sep 2024 Director of the Company (current)
1980-06-20
Susumu KIMURA
Director
Apr 1996 Joined the Company, Technical Office Dec 2017 Team Leader, Quality Group, Manufacturing Control Section, Production Management Department Jan 2019 Deputy General Manager, Technology Development Department Jul 2019 Deputy General Manager, Technology Management Division; General Manager, Electronics Design Department Nov 2023 General Manager, Technology Management Division Sep 2024 Director of the Company (current)
1967-08-11
Daisuke OGIWARA
Director
Oct 1994 Joined Century Audit Corporation (now EY ShinNihon LLC) May 1998 Registered as Certified Public Accountant Jan 2002 Opened Ogiwara Certified Public Accountant Office (current) May 2002 Registered as Certified Tax Accountant Sep 2007 Audit & Supervisory Board Member of the Company Sep 2019 Full-time Audit & Supervisory Board Member of the Company; Audit & Supervisory Board Member, NPS Co., Ltd. Sep 2020 Outside Director of the Company (current)
1971-05-14
Naoyuki TAMURA
Director
Jun 2013 Director, Roland Corporation Nov 2014 Senior Executive Officer, Roland Corporation; Executive Vice President, Roland Corporation U.S. Jan 2018 Global CFO, Roland Corporation Nov 2019 Senior Executive Officer (in charge of Corporate Planning), Roland Corporation May 2022 Director, Thinkings Co., Ltd. Jan 2024 Adviser, Roland Corporation May 2025 Adviser, the Company Sep 2025 Outside Director of the Company (current)
1964-05-08
Toru SHIMIZU
Full-time Audit & Supervisory Board Member
Apr 2001 Joined the Company, Purchasing Office Manager, Technology Management Department Jul 2005 General Manager, Quality Assurance Department Feb 2011 Director, Genetein Co., Ltd.; General Manager, Quality Assurance Department of the Company Sep 2014 Director, Genetein Co., Ltd.; Head of Production Division of the Company Jul 2016 Head of Production Division of the Company Dec 2017 Assistant General Manager, Technology Development Department Jul 2019 Assistant General Manager, Product Support Department Jul 2020 Adviser of the Company Sep 2024 Audit & Supervisory Board Member of the Company (current)
1956-10-08
Kentaro HEYA
Audit & Supervisory Board Member
Dec 2007 Joined Shin Nihon LLC (now EY ShinNihon LLC) Oct 2012 Registered as Certified Public Accountant Jul 2016 Opened Heya Certified Public Accountant Office (current) Nov 2016 Registered as Certified Tax Accountant Dec 2017 Designated Member, Orinas Partners Tax Corporation Sep 2019 Substitute Audit & Supervisory Board Member of the Company Sep 2020 Full-time Audit & Supervisory Board Member of the Company Sep 2022 Audit & Supervisory Board Member of the Company (current)
1978-11-26
Kayoko MOTOJIMA
Audit & Supervisory Board Member
Apr 2000 Registered as Attorney-at-Law (Tokyo Bar Association); joined White & Case Law Office Apr 2004 Established Koike & Motojima Law Office (current) Sep 2019 Audit & Supervisory Board Member of the Company (current)
1969-05-21
Yasuhiro SUZUKI
Audit & Supervisory Board Member
Apr 2003 Joined NTT DoCoMo, Inc. Dec 2008 Joined Shin Nihon LLC (now EY ShinNihon LLC) Oct 2012 Registered as Certified Public Accountant Sep 2017 Opened Yasuhiro Suzuki Certified Public Accountant Office (current) Oct 2017 Registered as Certified Tax Accountant Dec 2017 Designated Member, Orinas Partners Tax Corporation Sep 2019 Audit & Supervisory Board Member of the Company (current)
1979-12-19
Large Shareholding Reports
Nomura Securities Co., Ltd.
2025-10-06
4.97%→2.17%
Nomura Securities Co., Ltd.
2025-08-19
5.87%→4.97%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-09-18
Annual Securities Report
Period: Jul 2025 – Jun 2026
TDnet
2026-09-03
株主総会招集通知
FY ending Jun 2026
TDnet
2026-08-18
Full-Year Earnings Flash
FY ending Jun 2026
TDnet
2026-05-15
Q3 Earnings Flash
FY ending Jun 2026
EDINET
2026-02-16
Semi-Annual Securities Report
Period: Jul 2025 – Jun 2026
TDnet
2025-11-14
Q1 Earnings Flash
FY ending Jun 2026
EDINET
2025-10-06
Large Shareholding Report
EDINET
2025-09-29
Annual Securities Report
Period: Jul 2024 – Jun 2025
EDINET
2025-08-19
Large Shareholding Report
TDnet
2025-05-15
Q3 Earnings Flash
FY ending Jun 2025
EDINET
2025-02-14
Semi-Annual Securities Report
Period: Jul 2024 – Jun 2025
TDnet
2024-11-14
Q1 Earnings Flash
FY ending Jun 2025
EDINET
2024-09-30
Annual Securities Report
Period: Jul 2023 – Jun 2024
EDINET
2024-05-15
Quarterly Securities Report
Period: Jan 2024 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-14
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-09-29
Annual Securities Report
Period: Jul 2022 – Jun 2023
EDINET
2023-05-15
Quarterly Securities Report
Period: Jan 2023 – Mar 2023
EDINETAmended
2023-02-17
Amended Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2023-02-14
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-11
Quarterly Securities Report
EDINET
2022-09-30
Annual Securities Report
EDINET
2022-05-13
Quarterly Securities Report
EDINET
2022-02-14
Quarterly Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-09-29
Annual Securities Report
EDINET
2021-05-14
Quarterly Securities Report
EDINET
2021-02-12
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →